Development of eptifibatide

This publication has 32 references indexed in Scilit:

• The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions
  Molecular Immunology, 1995
• Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy
  Circulation, 1995
• NOVEL ANTITHROMBOTIC THERAPEUTICS TARGETED AGAINST PLATELET GLYCOPROTEIN IIb/IIIa
  Annual Review of Medicine, 1995
• Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1994
• Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
  New England Journal of Medicine, 1994
• Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab thrombolytic therapy: Results of the thrombolysis and angioplasty in mycardial infaraction (TAMI) 8 pilot study
  Journal of the American College of Cardiology, 1993
• Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein llb/llla in patients undergoing elective coronary angioplasty
  Coronary Artery Disease, 1993
• The platelet membrane glycoprotein IIb-IIIa complex
  Blood, 1988
• The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks.
  Circulation, 1988
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980